Novo Nordisk today inked a partnership deal with diabetes industry-focused company Lyfebulb to promote the development of innovative diabetes solutions using consumer or medical devices. New York-based Lyfebulb said it will focus on “patient entrepreneurs” who are developing concepts for diabetes management using devices and healthcare information technology. “This partnership with Novo Nordisk marks a milestone […]